The CTE Advisory Board to the Board of Directors of TSOI is dedicated to the specific field of CTE injury
prevention and treatment.
CTE or Chronic Traumatic Encephalopathy is caused by repetitive concussive/sub-concussive hits to the head sustained over a period of years and is often found in football players. The condition is characterized by memory loss, impulsive/erratic behavior, impaired judgment, aggression, depression, and dementia. In many patients with CTE, it is anatomically characterized by brain atrophy, reduced mass of frontal and temporal cortices, and medial temporal lobe.
Mr. Wes Chandler, the Chairman, was a wide receiver in the National Football League (NFL) for eleven seasons during the 1970s and 1980s. He was selected to the Pro Bowl four times and ranked twelfth in NFL history in receiving yards and thirteenth in receptions when he retired. Chandler is a member of the San Diego Chargers Hall of Fame. He played college football for the Florida Gators and was also inducted into the College Football Hall of Fame in 2015.
Wes Chandler was born in New Smyrna Beach, Florida. He attended New Smyrna Beach High School, where he was a standout high school football player for coach Bud Asher’s New Smyrna Beach Barracudas (“Cudas” to the fans). In his junior year the team was undefeated, including a victory over the Interlachen Rams of Interlachen High School which snapped their 21-game regular season win streak. Chandler scored twenty-two touchdowns as a senior in 1973 (scoring five in a single game), and rushing for 1,052 yards and catching twenty-two receptions as a wishbone halfback. Prominent with him in the backfield were the brothers Reggie and Keith Beverly. Chandler earned the nickname “Little Joe” due to his small size. In 2007, thirty-three years after he graduated from high school, the Florida High School Athletic Association (FHSAA) recognized Chandler as one of the “100 Greatest Players of the First 100 Years” of Florida high school football.
Dr. James Veltmeyer, the Vice-Chairman, is a board-certified family physician in La Mesa, California. A graduate of UC San Diego and the Ross University School of Medicine, he completed his residency through the UC San Francisco system where he became Chief of Family Medicine Residency, overseeing 36 doctors.
Dr. Veltmeyer, a member of the San Diego Critical Care Medical Group, has been elected for four years (2012, 2014, 2016, and 2017) by his colleagues in the San Diego County Medical Society as a “Physician of Exceptional Excellence,” the most prestigious honor awarded to a “Top Doctor” in San Diego County. He is among a select group of San Diego physicians who was chosen four of the last fifteen years and he consistently ranks in the top 1% to 2% for patient satisfaction. He is currently the Chief of the Department of Family Medicine at Sharp Grossmont Hospital where he provides senior leadership to over 200 doctors.
Dr. Thomas E. Ichim is a seasoned biotechnology entrepreneur with a track record of scientific excellence. He has founded/co-founded several companies including Batu Biologics, Inc., Medvax Pharma Corp, ToleroTech Inc, bioRASI, and OncoMune LLC. To date, he has published 99 peer-reviewed articles and is co-editor of the textbooks “RNA Interference: From Bench to Clinical Translation” and “Immuno-Oncology Text Book.”
Dr. Ichim is an ad-hoc editor and sits on several editorial boards. Dr. Ichim is an inventor on over 50 patents and patent applications. Dr. Ichim has extensive experience with stem cell therapy and cellular product development through FDA regulatory pathways. Dr. Ichim spent over 7 years as the President and Chief Scientific Officer of Medistem, developing and commercializing a novel stem cell, the Endometrial Regenerative Cell, through drug discovery, optimization, preclinical testing, IND filing, and up through Phase II clinical trials with the FDA. Dr. Ichim has extensive experience in product development, regulatory filings, and business development.
Dr. Ichim has a BSc in Biology from the University of Waterloo, Waterloo, Ontario, Canada, an MSc in Microbiology and Immunology a University of Western Ontario, London, Ontario, Canada and a Ph.D. in Immunology from the University of Sciences Arts and Technology, Olveston Monserrat.
Timothy G. Dixon currently serves as Chief Executive Officer, President, and Chairman of Therapeutic Solutions International, Inc. Mr. Dixon previously served as the President of TMD Courses, Inc. from 2006 to 2012 and; as the President of Splint Decisions Inc. from 2010 to 2011.
Mr. Dixon has attended hundreds of hours of continuing medical/dental education throughout the years and has produced many educational DVD’s used by dental professionals worldwide on the subject of parafunctional control, migraine prevention, therapeutic Botox injections, migraine pathophysiology, dental sleep medicine, and other therapeutic protocols. Mr. Dixon also has extensive experience in dealing with corporate compliance matters with the U.S. Food and Drug Administration, (FDA) as well as many international regulatory bodies.